Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.90p
   
  • Change Today:
    -0.14p
  • 52 Week High: 3.42
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 1,925,128
  • Market Cap: £7.91m
  • RiskGrade: 328

Thrusday broker round-up

By Caoimhe Toman

Date: Thursday 18 Jan 2018

LONDON (ShareCast) - (ShareCast News) - Rightmove: JP Morgan upgrades to neutral with a target price of 4,168p.
CYBG PLC: Berenberg reiterates buy with a target price of 375p.

Metro Bank plc: Berenberg reiterates sell with a target price of 3,000p.

Clinigen Group plc: Berenberg upgrades to buy with a target price of 1,220p.

Burberry group: Deutsche Bank reiterates hold with a target price of 1,625p.

GKN plc: Citigroup reiterates neutral with a target price of 430.1p.

South32 ltd: Citigroup downgrades to neutral with a target price of 220p.

Purplebricks: JP Morgan initiates at overweight with a target price of 733p.

Imperial brands plc: JP Morgan reiterates neutral with a target price of 3,275p.

Hochschild: JP Morgan reiterates underweight with a target price of 220p.

Rio Tinto plc: JP Morgan reiterates neutral with a target price of 4,000p.

Pearson: JP Morgan reiterates neutral with a target price of 760p.

Provident financial: JP Morgan reiterates neutral with a target price of 1,100p.

Hargreaves Landsdown: Barclays reiterates overweight with a target price of 2,100p.

AA plc: Barclays reiterates overweight with a target price of 200p.

Mattioli Woods: Canaccord reiterates buy with a target price of 860p.

Rathbone brothers: Canaccord reiterates hold with a target price of 2,705p.

Gulf Keystone: Canaccord reiterates speculative buy with a target price of 220p.

Halfords: Canaccord reiterates hold with a target price of 370p.

Safe Change International: Canaccord reiterates buy with a target price of 380p.

Whitbread: Canaccord reiterates buy with a target price of 4,500p.

Immupharma: Northland Capital Markets reiterates buy with a target price of 181p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.90p
Change Today -0.14p
% Change -6.86 %
52 Week High 3.42
52 Week Low 0.85
Volume 1,925,128
Shares Issued 416.44m
Market Cap £7.91m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
62.34% below the market average62.34% below the market average62.34% below the market average62.34% below the market average62.34% below the market average
9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average
Price Trend
44.24% below the market average44.24% below the market average44.24% below the market average44.24% below the market average44.24% below the market average
12.73% above the sector average12.73% above the sector average12.73% above the sector average12.73% above the sector average12.73% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:28 419,759 @ 2.00p
16:29 20,000 @ 2.00p
16:29 47,619 @ 2.01p
16:28 69,550 @ 2.00p
16:28 250,000 @ 2.00p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page